CD19 and BCMA-specific CAR T cells are also being repurposed for the treatment of autoimmune diseases, where autoreactive cells of the B cell lineage (B cells themselves, plasmablasts, and plasma cells) are central mediators of disease pathology (14, 15). The gene discussed is TNFRSF17; the disease is autoimmune disease.